Scientific paper - Original scientific paper
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
Journal of Personalized Medicine, 11 (2021), 4; 269. https://doi.org/10.3390/jpm11040269

Basile, Vittoria; Puglisi, Soraya; Altieri, Barbara; Canu, Letizia; Libè, Rossella; Ceccato, Filippo; Beuschlein, Felix; Quinkler, Marcus; Calabrese, Anna; Perotti, Paola; Berchialla, Paola; Dischinger, Ulrich; Megerle, Felix; Baudin, Eric; Bourdeau, Isabelle; Lacroix, André; Loli, Paola; Berruti, Alfredo; Kaštelan, Darko; Haak, Harm R.; Fassnacht, Martin; Terzolo, Massimo More authors...

Cite this document

Basile, V., Puglisi, S., Altieri, B., Canu, L., Libè, R., Ceccato, F. ... Terzolo, M. (2021). What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question. Journal of Personalized Medicine, 11. (4). doi: 10.3390/jpm11040269

Basile, Vittoria, et al. "What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question." Journal of Personalized Medicine, vol. 11, no. 4, 2021. https://doi.org/10.3390/jpm11040269

Basile, Vittoria, Soraya Puglisi, Barbara Altieri, Letizia Canu, Rossella Libè, Filippo Ceccato, Felix Beuschlein, et al. "What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question." Journal of Personalized Medicine 11, no. 4 (2021). https://doi.org/10.3390/jpm11040269

Basile, V., et al. (2021) 'What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question', Journal of Personalized Medicine, 11(4). doi: 10.3390/jpm11040269

Basile V, Puglisi S, Altieri B, Canu L, Libè R, Ceccato F, and sur.. What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question. Journal of Personalized Medicine [Internet]. 2021 April 04 [cited 2024 March 28];11(4). doi: 10.3390/jpm11040269

V. Basile, et al., "What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question", Journal of Personalized Medicine, vol. 11, no. 4, April 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:323240. [Accessed: 28 March 2024]

Please login to the repository to save this object to your list.